
CPHI Milan 2026
10/2026 – 10/2026
Zerion Pharma A/S is a pharmaceutical development company improving the formulation of poorly soluble drugs (oral solid dosage forms) that are currently not reaching their therapeutic potential. Through its proprietary formulation platform, Dispersome, the company aims to develop new treatment options for patients across all therapeutic areas.

Aucun commentaire disponible.
Laissez votre note & commentaire